Respiratory syncytial virus causes lower respiratory tract illnesses such as bronchiolitis or pneumonia. To stop its expansion, Pfizer developed the first-to-market vaccine aimed at pregnant women and women over 60 years of age. This virus accounts for more than 60% of acute respiratory infections in infants and young children worldwide. The vaccine, through immunization of the mother, gives the baby antibodies during the first six months of life, when the baby is most vulnerable. Adults can also suffer severe illness from syncytial virus, especially those who are over 60 years of age or have chronic heart disease, COPD, asthma, or are immunocompromised. The vaccine is now available in Spain and should be used in accordance with official recommendations. It is given as a single dose to pregnant women between 24 and 36 weeks’ gestation. As for the indications for active immunization of persons over 60 years of age for the prevention of RSV disease, they are not included in the reimbursement of the General Pharmacy Directorate.
Article for subscribers only
Unlimited access to better journalism
See comments
Austin Butler produced a film about the journey of that time called Barrier with the…
The leader of North Korea this Thursday criticized the latest steps by Ukraine, the United…
Leonardo Garma and Miguel Quintela in the laboratory of the Clinical Department of Breast Cancer…
The Ministry of Social Rights, Consumption and the 2030 Agenda fined low-cost airlines Ryanair, Vueling,…
VALENCIA (EP). According to the latest “House Commission” carried out by the National Commission of…
Press conference by Marcelino García Toral before the match with Osasuna. Villarreal coach Marcelino García…